Clinical neurochemistry: developments in dementia research based on brain bank material

[1]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[2]  C. Ballard,et al.  Neuropsychiatric aspects of alzheimer’s disease , 1999, Current psychiatry reports.

[3]  E K Perry,et al.  D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. , 1997, Pharmacogenetics.

[4]  K. R. Weiss,et al.  Analyzing the functional consequences of transmitter complexity , 1997, Trends in Neurosciences.

[5]  Raymond Scott Turner,et al.  Probable diffuse Lewy body disease presenting as REM sleep behavior disorder , 1997, Neurology.

[6]  Margaret A. Johnson,et al.  Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. , 1997, Brain research. Developmental brain research.

[7]  E. Perry,et al.  Nicotinic receptor distribution in the human thalamus: autoradiographical localization of [3H]nicotine and [125I]α-bungarotoxin binding , 1997, Journal of Chemical Neuroanatomy.

[8]  A. Hofman,et al.  Histamine H2 Blocking Drugs and the Risk for Alzheimer’s Disease: The Rotterdam Study , 1997, Neurobiology of Aging.

[9]  N. Cairns,et al.  Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer disease , 1997, Neuroscience Letters.

[10]  L Kruglyak,et al.  Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  L. Friedhoff,et al.  The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial , 1996 .

[12]  D. Uhlrich,et al.  Histamine‐immunoreactive neurons and their innervation of visual regions in the cortex, tectum, and thalamus in the primate Macaca mulatta , 1996, The Journal of comparative neurology.

[13]  S. Minoshima,et al.  In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease , 1996, Annals of neurology.

[14]  Mark W. Mahowald,et al.  Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder , 1996, Neurology.

[15]  J. Missimer,et al.  Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease. , 1995, Archives of neurology.

[16]  G. Celesia,et al.  Regional alterations in M1 muscarinic receptor-G protein coupling in Alzheimer's disease. , 1995, Journal of neuropathology and experimental neurology.

[17]  G. Celesia,et al.  Regional Alterations in M., Muscarinic Receptor-G Protein Coupling in Alzheimer's Disease , 1995 .

[18]  E. Perry,et al.  Acetylcholine and Hallucinations - Disease-Related Compared to Drug-Induced Alterations in Human Consciousness , 1995, Brain and Cognition.

[19]  M. Pericak-Vance,et al.  Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs , 1995, Neurobiology of Aging.

[20]  P. Rowell.  Nanomolar concentrations of nicotine increase the release of [3H]dopamine from rat striatal synaptosomes , 1995, Neuroscience Letters.

[21]  M. Uchiyama,et al.  Incidental Lewy body disease in a patient with REM sleep behavior disorder , 1995, Neurology.

[22]  R. T. Carroll,et al.  Cholinergic therapies for Alzheimer's disease. Palliative or disease altering? , 1995, Arzneimittel-Forschung.

[23]  D. Irving,et al.  Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology , 1995, Neuroscience.

[24]  J. Growdon,et al.  Role of neurotransmission in the regulation of amyloid beta-protein precursor processing. , 1994, Biochemical pharmacology.

[25]  A. C. Collins,et al.  Desensitization of Nicotine‐Stimulated [3H]Dopamine Release from Mouse Striatal Synaptosomes , 1994, Journal of neurochemistry.

[26]  Mrinalini Honavar,et al.  Lewy bodies and response to tacrine in Alzheimer's disease , 1994, The Lancet.

[27]  I. Kanazawa,et al.  Abnormalities in muscarinic cholinergic receptors and their G-protein coupling systems in the cerebral frontal cortex in Alzheimer's disease. , 1993, Archives of gerontology and geriatrics.

[28]  J. Kimura,et al.  Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammillary nucleus of patients with Alzheimer's disease , 1993, Neuroscience Letters.

[29]  A. Nordberg,et al.  Coupling of muscarinic receptors to GTP proteins in postmortem human brain — alterations in Alzheimer's disease , 1993, Neuroscience Letters.

[30]  J. Hobson.  Sleep and dreaming: induction and mediation of REM sleep by cholinergic mechanisms. , 1992, Current opinion in neurobiology.

[31]  M M Mesulam,et al.  Cholinergic innervation of the human thalamus: Dual origin and differential nuclear distribution , 1992, The Journal of comparative neurology.

[32]  E. Perry,et al.  Neuroleptic sensitivity in patients with senile dementia of Lewy body type. , 1992, BMJ.

[33]  R. Schwartzman,et al.  Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys , 1992, Brain Research.

[34]  A. Lajtha,et al.  Dopamine Efflux from Striatum After Chronic Nicotine: Evidence for Autoreceptor Desensitization , 1992, Journal of neurochemistry.

[35]  J. Schwartz,et al.  Pharmacological Characterization and Autoradiographic Localization of Histamine H2 Receptors in Human Brain Identified with [125I]Iodoaminopotentidine , 1992, Journal of neurochemistry.

[36]  E. Perry,et al.  Convergent cholinergic activities in aging and Alzheimer's disease , 1992, Neurobiology of Aging.

[37]  A. Paetau,et al.  Histamine neurons in human hypothalamus: Anatomy in normal and alzheimer diseased brains , 1991, Neuroscience.

[38]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[39]  E. Perry,et al.  Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease , 1990, Journal of the Neurological Sciences.

[40]  E. Perry,et al.  Evidence of a Monoaminergic‐Cholinergic Imbalance Related to Visual Hallucinations in Lewy Body Dementia , 1990, Journal of neurochemistry.

[41]  J. Schwartz,et al.  Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates , 1990, Brain Research.

[42]  A. Parent.  Extrinsic connections of the basal ganglia , 1990, Trends in Neurosciences.

[43]  E. Hirsch,et al.  Compartmental ordering of cholinergic innervation in the mediodorsal nucleus of the thalamus in human brain , 1990, Brain Research.

[44]  Robert H. Perry,et al.  Senile dementia of Lewy body type A clinically and neuropathologically distinct form of Lewy body dementia in the elderly , 1990, Journal of the Neurological Sciences.

[45]  E. Perry,et al.  Cholinergic and Dopaminergic Activities in Senile Dementia of Lewy Body Type , 1990, Alzheimer disease and associated disorders.

[46]  M. Descheˆnes,et al.  The effects of brainstem peribrachial stimulation on perigeniculate neurons: The blockage of spindle waves , 1989, Neuroscience.

[47]  D. Grandy,et al.  The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. , 1989, American journal of human genetics.

[48]  E. Perry,et al.  SENILE DEMENTIA OF LEWY BODY TYPE AND SPECTRUM OF LEWY BODY DISEASE , 1989, The Lancet.

[49]  D. Benson,et al.  Alzheimer's disease and Parkinson's disease , 1988, Neurology.

[50]  P Riederer,et al.  Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. , 1987, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[51]  D. McCormick,et al.  Actions of acetylcholine in the guinea‐pig and cat medial and lateral geniculate nuclei, in vitro. , 1987, The Journal of physiology.

[52]  J. A. Hobson,et al.  Evolving concepts of sleep cycle generation: From brain centers to neuronal populations , 1986, Behavioral and Brain Sciences.

[53]  P. Gaspar,et al.  l‐Histidine Decarboxylase in the Human Brain: Properties and Localization , 1980, Journal of neurochemistry.

[54]  V. Gerzanich,et al.  Structure and function of neuronal nicotinic acetylcholine receptors. , 1996, Progress in brain research.

[55]  A. Maelicke,et al.  Nicotinic acetylcholine receptors on hippocampal neurons: cell compartment-specific expression and modulatory control of channel activity. , 1996, Progress in brain research.

[56]  R Freedman,et al.  Nicotinic receptor function in schizophrenia. , 1996, Schizophrenia bulletin.

[57]  E. Perry,et al.  Age-associated decline in high-affinity nicotine binding in human brain frontal-cortex does not correlate with the changes in choline-acetyltransferase activity , 1992 .

[58]  E. Bird,et al.  Organization of dopamine D1 and D2 receptors in human striatum: Receptor autoradiographic studies in Huntington's disease and schizophrenia , 1988, Synapse.